CRWV

CoreWeave went public on March 28, 2025, raising $1.5 billion. Core Scientific shareholders rejected a merger agreement with CoreWeave, leading to a stock price drop. CoreWeave lowered its guidance for revenue, operating income, capital spending, and active power capacity for 2025, causing the stock to drop. A shareholder complaint was filed, alleging securities fraud against CoreWeave. A class action lawsuit was filed against CoreWeave and its senior executives, accusing them of securities fraud. CoreWeave reported its first-quarter 2026 financial results, showcasing record bookings and a revenue backlog nearing $100 billion, but the adjusted EPS loss was wider than anticipated, and the company's second-quarter revenue guidance missed analyst expectations, leading to a significant stock decline. Despite these recent drops, CoreWeave's stock has rallied sharply in 2026.